The high levels of GABA could in turn bind to GABAB receptors, inhibiting synaptic release in APP/PS1 mice.245 GABAB antagonists were proposed to decrease the inhibition of synaptic function and enhance cognition in AD.245. This evidence concerns the gene APP and Alzheimer disease.